Immix Biopharma Q3 EPS $(0.19), Inline

Benzinga · 4d ago
Immix Biopharma (NASDAQ:IMMX) reported quarterly losses of $(0.19) per share which met the analyst consensus estimate. This is a 20.83 percent increase over losses of $(0.24) per share from the same period last year.